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Abstract Although adult skeletal muscle is com-
posed of fully differentiated fibers, it retains the
capacity to regenerate in response to injury and to
modify its contractile and metabolic properties in
response to changing demands. The major role in the
growth, remodeling and regeneration is played by
satellite cells, a quiescent population of myogenic
precursor cells that reside between the basal lamina
and plasmalemma and that are rapidly activated in
response to appropriate stimuli. However, in
pathologic conditions or during aging, the complete
regenerative program can be precluded by fibrotic
tissue formation and resulting in functional impair-
ment of the skeletal muscle. Our study, along with
other studies, demonstrated that although the regen-
erative program can also be impaired by the limited
proliferative capacity of satellite cells, this limit is not
reached during normal aging, and it is more likely that
the restricted muscle repair program in aging is
presumably due to missing signals that usually render
the damaged muscle a permissive environment for
regenerative activity.
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Introduction
Mature skeletal muscle is composed of myofibers,
which are multinucleated syncytia arising from the
fusion of mononucleated precursor cells. In addition,
there is a population of mononucleated muscle stem
cells, known as satellite cells, that reside at the
periphery of muscle fibers between the basal lamina
and the sarcolemma. Historically, satellite cells were
identified using electron microscopy by Mauro (1961),
who reported that satellite cells might be ‘‘dormant
myoblasts that failed to fuse with other myoblasts and
are ready to recapitulate the embryonic development
of the skeletal muscle fibers when the main multinu-
cleate cell is damaged’’.
Since these early observations, it has become
evident that muscle regeneration is a coordinated
process in which multiple factors are sequentially
activated to restore and/or preserve muscle structure
and function upon injury and represents an essential
homeostatic process, which guarantees the mainte-
nance of muscle integrity and plasticity. In response to
damage, fibre regeneration must be finely orchestrated
between the different cellular and molecular partners,
such as inflammatory, anti-inflammatory or interstitial
cells or signaling pathways, to lead from degenerating
fibres to a newly regenerated and functional tissue
with its pool of precursors restored for future repair.
The phases of muscle regeneration
Muscle regeneration and repair occur in four interre-
lated and time-dependent phases: degeneration,
inflammation, regeneration, and remodeling-repair
(Carosio et al. 2011; Tidball and Villalta 2010)
(Fig. 1a). Injury of myofibers results in rapid necrosis,
due to an influx of extracellular calcium that induces
proteolysis of the myofibers (Oberc and Engel 1977).
The presence of necrotic fibers activates a defined
inflammatory response (Fig. 1b) that is characterized
by the sequential invasion of the muscle by specific
inflammatory cell populations. Although neutrophils
are the first inflammatory cells to arrive at the sites of
lesion, macrophages are the predominant inflamma-
tory cell type which rapidly infiltrates the injured area
and several findings suggest that macrophages play a
key role not only in removing tissue debris, but also in
the activation of stem cell-mediated muscle repair and
regeneration (St. Pierre BA and Tidball JG 1994;
Arnold et al. 2007) by secreting cytokines and growth
factors (Paliwal et al. 2012) (Fig. 1a). Two different
classes of macrophages, known as M1 and M2, have
been described and characterized (Mantovani et al.
2004) (Fig. 1a). M1 macrophages are the first macro-
phages to invade injured muscle following acute
damage, where they produce proinflammatory cyto-
kines and may cause further tissue damage through the
release of nitric oxide (Nguyen and Tidball 2003; St.
Pierre and Tidball 1994; Krippendorf and Riley 1993).
M1 macrophages also exert a pro-proliferative effect
on other types of cells, including activated satellite
cells, referred to as myoblasts in this activated state
(Arnold et al. 2007; Bencze et al. 2012; Paliwal et al.
2012).
M2 macrophages, which progressively replace M1
macrophages at sites of injury, have been shown to
play a major role in promoting growth and regener-
ation. In contrast to M1, M2 cells tune the inflamma-
tory response, scavenge debris and promote
angiogenesis, tissue remodeling and repair (St. Pierre
and Tidball 1994; Krippendorf and Riley 1993;
Tidball and Wehling-Henricks 2007): their absence
causes a delay in muscle growth and inhibits muscle
differentiation and regeneration. Thus, this transition
in macrophage phenotype is an essential component of
muscle regeneration in vivo following acute or chronic
muscle damage (Tidball and Villalta 2010).
This initial inflammatory response is followed by a
phase of active regeneration (Fig. 1a), characterized
by satellite cell activation, and initiation of regener-
ating fibers, which can be morphologically identified
in the mouse by the presence of characteristic central
nuclei (Karpati and Molnar 2008), which are the result
of the differentiation of activated satellite cells
(Zammit et al. 2002; Tajbakhsh 2009).
The final phases of myofibre regeneration include: a
period during which maturation of contractile apparatus
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occurs, where destruction has been extensive, innerva-
tions is re-established, remodeling of extracellular
matrix is initiated (impacting on scar tissue formation
(Fig. 1a) and recovery of the functional performance of
the injured muscle occurs (Goetsch et al. 2003).
The cellular basis of muscle regeneration:
the role of satellite cells and non-muscle
stem cells on muscle regeneration
The importance of satellite cells in muscle repair
promoted the characterization of molecular markers
selectively expressed by satellite cells, but not by
muscle fibers. It has been reported that Pax3, Pax7,
M-cadherin, FoxK, NCAM, syndecans 3 and 4, CD34
and VCAM-1 are all markers expressed by quiescent
satellite cells (Fig. 1b) (Carosio et al. 2011; Hawke
and Garry 2001; Zammit 2008; Buckingham 2007).
Once activated, satellite cells up-regulate expression
of c-Met, Pax-7 and M-cadherin and also activate the
expression of factors involved in the specification of
the myogenic program such as myf-5 and MyoD
(Fig. 1b). The activated satellite cells proliferate as
indicated by the expression of transcription factors
involved in cell cycle progression (Fig. 1b) and by the
incorporation of BrdU and [3H] thymidine (Yin et al.
2013). Ultimately the committed satellite cells will
either fuse with each other, or to the existing fibers, to
form new muscle fibers, which are characterized by
their small size and in rodents by the presence of
characteristic central nuclei. The transition from cell
proliferation to differentiation involves myogenic
factor as MyoD (Halevy et al. 1995) and the exit from
the cell cycle by upregulation of factors such as p21
(Guo et al. 1995) or p57 as demonstrated in vitro
(Reynaud et al. 2000; Bigot et al. 2008) and later the
activation of other muscle specific protein genes,
including the embryonic and neonatal isoforms of the
myosin heavy chain (MyHC) (Carosio et al. 2011)
Fig. 1 Schematic model depicting muscle regeneration.
(a) Schematic representation of the four interrelated and time-
dependent phases underlying muscle regeneration. The relevant
biological responses, activated after cardiotoxin (CTX)
injection, are indicated. (b) Schematic model outlining the
relevant markers expressed by satellite cells during the different
stages of regeneration. (h: hours; d: days). stages of muscle
regeneration that could be impaired in muscle aging
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(Fig. 1b). The kinetics of muscle regeneration has also
been investigated in vivo using implantation of human
satellite cells into the regenerating tibialis anterior
(TA) of immunodeficient mice. Satellite cell death at
implantation varies depending on the experimental
conditions and can reach over 90 % (Beauchamp et al.
1999; Skuk and Tremblay 2003); implanted human
cells proliferate during a relatively limited period of
time and differentiate as early as 3–5 days post-
transplantation, a time-point after which there is no
more proliferation and no more dispersion of satellite
cells within the regenerating muscle (Riederer et al.
2012).
Several studies have also raised the possibility that
satellite cells are a heterogeneous mixture of stem
cells and committed myogenic progenitors (Schultz
and Lipton 1982; Grounds and McGeachie 1987;
Moss and Leblond 1971; Schultz 1996). This hypoth-
esis was supported by radioisotope labeling experi-
ments, demonstrating that rat satellite cells are a
mixture of 80 % fast-cycling cells and 20 % slow-
cycling ‘‘reserve cells’’ (Schultz 1996). Asymmetric
division of stem cells in the satellite cell niche is a
mechanism proposed for generating these two differ-
ent populations (Kuang et al. 2007). In particular,
Pax7-positive satellite cells that lack Myf5 expression
have a ‘‘stem-like’’ phenotype within the satellite cell
population. In contrast, Pax7-positive satellite cells
expressing Myf5 were more committed to a muscle
fate (Kuang et al. 2007). It has also been proposed that
other ‘‘non-muscle’’ stem cell populations can partic-
ipate in muscle regeneration and in some way
contribute to maintaining the pool of satellite cells.
These stem cell populations could either reside within
muscle, or be recruited via the circulation in response
to homing signals emanating from the injured skeletal
muscle. These populations include endothelial-asso-
ciated cells (De Angelis et al. 1999), interstitial cells
(Kuang et al. 2006; Polesskaya et al. 2003; Tamaki
et al. 2002) and bone marrow-derived stem cells
(Asakura et al. 2002; Gussoni et al. 1999). However,
these cells rarely participate to the formation of
muscle fibres (Ferrari et al. 2001, Partridge 2004).
Nevertheless, even though skeletal muscle pos-
sesses a stem cell compartment, which decreases with
age in rat, mice and humans (Snow 1977; Collins et al.
2007; Sajko et al. 2004; Verdijk et al. 2007; Renault
et al. 2002; Kadi et al. 2004; Chakkalakal et al. 2012) it
is not sufficient to explain why the aged muscle
presents such a diminished efficiency to regenerate.
Either the potency of the resident muscle stem cells
drastically decreases during aging or perhaps the
senescent muscle is a prohibitive environment for
stem cell activation and function.
The limit in proliferation of satellite cells
Once activated, a minority of cells will restore the
satellite cell compartment through an asymmetric
division (Conboy and Rando 2002; Tajbakhsh 2009),
while the majority will proliferate extensively before
entering terminal differentiation to replace the dam-
aged muscle fibres.
Telomere shortening during proliferation may con-
tribute to the inability of satellite cells to perpetually
repair muscle during aging. Human satellite cells, like
most somatic cells of the body, lack telomerase
expression after birth, and their telomeres will shorten
at each cell division until they reach a critical length
which triggers proliferative arrest or senescence (De-
cary et al. 1997; Di Donna et al. 2003). Studies
conducted in vitro showed that human satellite cells
reach proliferative arrest with up to 7–9 kb of intact
telomere length, while fibroblasts will reach prolifer-
ative arrest with 6 kb. This discrepancy is due to the
triggering of another pathway that blocks the cell
cycle, at least in vitro. This pathway is stress induced
and involves the upregulation of p16, which binds cdk4
and prevents this kinase from enabling cell cycle entry,
as demonstrated by the requirement for inactivating
both the p16 pathway and telomere shortening to
immortalize human myoblasts (Zhu et al. 2007,
Mamchaoui et al. 2011). Although it is not known
whether p16 can also trigger proliferative arrest of
activated satellite cells in vivo, the p16 pathway can be
prematurely activated in dystrophic conditions such as
myotonic dystrophy type 1 (DM1) where it triggers
premature proliferative arrest of myoblasts at least
in vitro (Bigot et al. 2009). Proliferative arrest is
probably never reached in control human subjects, but
can be a limiting factor in situations where repeated
cycles of degeneration/regeneration occur, such as
muscular dystrophies, as shown by reduced telomere
lengths in cells derived from models of these condi-
tions (Decary et al. 2000). Less is known regarding the
limit in proliferation of murine myoblasts. Mouse
myoblasts express telomerase, but their proliferation is
276 Biogerontology (2013) 14:273–292
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still limited, probably by the p16 pathway, since mouse
myoblasts can be immortalized by the overexpression
of cdk4 that traps p16, rendering it inactive (Douillard-
Guilloux et al. 2009).
Satellite cells display a delayed response
to activating stimuli and show a reduced
proliferative response to their sub-optimal
environment
To understand if proliferative aging could induce
modifications in the intrinsic properties of human
myoblasts, as approach to senescence does in vitro
(Bigot et al. 2008), we have monitored the prolifer-
ative capacity of myoblasts isolated from young and
old donors. As shown in Fig. 2, satellite cells isolated
from old adults were able to proliferate and to express
specific markers of activated and proliferating satellite
cells, such as desmin, Pax7, Ki67, and MyoD.
We compared the proliferative capacity of satellite
cells from five young donors (age range 15–24 year-
old) to that of 10 old donors (age range 68–80 year-
old) separated in two groups : five old sedentary and
five old active based on their examination by clinicians
and on a questionnaire on the lifestyle of the subjects.
In order to stimulate and maintain the cultures
proliferating for as long as possible, we cultured the
cells in the presence of 20 % of fetal calf serum. The
mean number of divisions made by each population,
calculated using the formula log (n/N)/log2 where n is
the number of cells counted at each passage and N the
number of cells plated initially, was determined as a
function of time in culture. The lifespan curves
resulting from these analyses are shown on Fig. 3.
The inter-individual differences between the life spans
within a group appear at least as important as the
differences between the groups. We also calculated the
mean number of division reached by the cultures in
each group when they were senescent, as defined by
the absence of any division during 3 weeks of
refeeding. No statistically significant difference was
observed between the maximum number of division
(PDL for population doubling level) in the three
groups. In order to determine the potential activation
of the p16 pathway in the cultures derived from young
and old subjects, we measured by qPCR the mRNA
level of p16 (Fig. 4a) and the telomere length (Fig. 4b)
at the beginning of the lifespan and that reached at
senescence for each culture, and no difference was
detected between young and old groups. In conclusion
of these experiments, cultures derived from old active
or sedentary subjects do not show any difference in
their proliferative capacity, nor do they differ from
those derived from young donors.
However, when cells were cultured in presence of
15 % of autologous or heterologous sera—which may
represent more physiological conditions—we
observed a significant difference in the rate of
proliferation when old-derived satellite cells were
compared with young-derived satellite cells. In par-
ticular, the proliferative capacity of the muscle cell
cultures was estimated from the cells incorporating
BrdU. For this experiment, young- and old-derived
satellite cells were plated at the same density and
immunofluorescence analyses revealed that the per-
centage of BrdU-positive cells was reduced in cultures
of old-derived satellite cells when cultured in autol-
ogous (homochronic) as compared to heterologous
(heterochronic from young donors), or to young
satellite cells (Fig. 5). These data support the evidence
that during aging, satellite cells display a delayed
response to activating stimuli and show a reduced
proliferative response to their environment (Schultz
and Lipton 1982; Conboy et al. 2003) when this
environment is sub-optimal.
The impaired satellite cells behaviour in sarcopenia
might be mediated by altered p53 expression/
activity
Regenerative potential decline in skeletal muscle with
aging could also depend on the activation in satellite
cells of p53 pathway. The tumor suppressor p53 is
activated by different stress signals, such as DNA
damage, leading to cell cycle arrest, apoptosis but also
telomere shortening driven senescence. The exact
function of p53 in skeletal muscle remains to be
clearly defined, although a recent study demonstrates
that p53 activation promotes atrophy in aging muscle,
suggesting a pivotal role in the homeostasis of satellite
cells (Schwarzkopf et al. 2008). In agreement to these
findings, we observed, by real time RT-PCR, an
increase in the expression levels of p53 in myoblasts
derived from old (age: 73.37 ± 2.66 year-old) sub-
jects with respect to young (age: 21.6 ± 2.23 year-
Biogerontology (2013) 14:273–292 277
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old). This result was also mirrored by the expression of
a p53 downstream gene, p21 that appeared to be
expressed at a higher level in older myoblasts com-
pared to those derived from younger subjects (Fig. 6).
Although telomere length, which can trigger the p53
pathway, do not seem to be statistically different
between cultures of satellite cells from young and old
subjects, other signals may be involved.
Human satellite cells fail to differentiate
when cultured in isochronic conditions
We then analysed the ability of satellite cells derived from
old subjects to differentiate when cultured in presence of
either heterologous/heterochronic (from young donors)
or autologous serum. Immunofluorescence analysis for
the expression of MyHC revealed that aged satellite cells
Fig. 2 Immunofluorescence analysis showing that aged satellite cells, in culture, express specific markers of activated and
proliferating satellite cells, such as Pax7, desmin, MyoD, and Ki67
Fig. 3 Proliferative capacity of human muscle precursor cells
(myoblasts) isolated from three groups of subjects (young, old
sedentary and old active). The proliferative lifespan was
determined on five distinct cultures isolated from five different
donors in each group of subjects
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did not display major defect in the propensity to fuse
when differentiated under standard conditions, namely in
DMEM supplemented with 5 % horse serum (data not
shown). Of note, we observed that autologous serum
(isochronic culture conditions) dramatically reduced
muscle differentiation (Fig. 7), which was partially
rescued when aged satellite cells were differentiated in
heterologous/heterochronic serum (from young donors)
(Fig. 7).
Of note, Beccafico et al. (2011) also demonstrated
that aged satellite cells show altered expression levels
of S100B, RAGE, and Pax7 and a reduced ability to
secrete bFGF and S100B among other factors, which
appear to be responsible for the defective proliferation
Fig. 4 p16 mRNA expression (a) and Telomere length
(b) were measured by qRT-PCR and qPCR respectively in
proliferative myoblasts at the beginning of their lifespan (P) and
in senescence myoblasts (S). Values are mean ± standard
deviation, n = 5 and 10 for young and old respectively
Fig. 5 Proliferation of aged satellite cells is impinged in
autologous culture conditions. Immunofluorescence analysis for
BrdU incorporation in satellite cells obtained from young
(30.3 ± 1.8 year-old) and old (83.3 ± 6.3 year-old) subjects,
cultured in either autologous serum (AS) or heterologous serum
(HS). Old-derived satellite cells showed a 21.3 % of BrdU-
positive cells when cultured in autologous (homochronic) serum
(middle panel), whereas old-derived satellite cells showed a
32.5 % of BrdU-positive cells when cultured in heterologous
(heterochronic from young donors) (right panel). Young-
derived satellite cells showed a 51 % of BrdU-positive cells
(left panel). No major differences in the percentage of BrdU-
positive cells were observed when young-derived satellite cells
were cultured in either autologous (homochronic) or heterolo-
gous (heterochronic from old donors) serum. Bottom panels
show Hoechst nuclear staining
Biogerontology (2013) 14:273–292 279
123
and differentiation. Indeed, the proliferation and differ-
entiation defects was rescued by cultivation of aged
satellite cells in young satellite cells conditioned media
which contain bFGF and S100B among others (Beccaf-
ico et al. 2011). It is plausible that the changes in these
intrinsic factors reflect changes in the aged satellite cells
microenvironment or alterations of the cellular machin-
ery regulating the expression levels of those factors.
Sarcopenia interferes with muscle regeneration:
an overview
What are the molecular and cellular mechanisms that
limit the senescent muscle to sustain an efficient
regenerative process?
The important seminal studies of Bruce Carlson
clearly indicated that skeletal muscle regeneration is
less successful in old than in young individuals
(Carlson 1968; Carlson 1972; Carlson 1973; Carlson
1995). Several factors might be involved: (1) reduced
number and altered proliferative potential of satellite
cells (Schultz and Lipton 1982; Gibson and Schultz
1983; McGeachie and Grounds 1995), (2) telomere
shortening in satellite cells (Renault et al. 2000), (3)
reduced innervations of senescent muscle (Larsson
1982; Larsson and Ansved 1995), (4) increased
fibrotic tissue (Marshall et al. 1989), (5) altered
expression and concentration of systemic, as well as
local growth factors and cytokines (Barton-Davis et al.
1998; Yablonka-Reuveni et al. 1999; Chakravarthy
et al. 2000; Grounds 2002; Cevenini et al. 2010), (6)
activation of apoptotic pathways (Fulle et al. 2012).
Different studies have reported divergent results
concerning satellite cells and ageing in mouse ranging
from a marked decline, to little change, to a relative
Fig. 6 p53 and p21 expression is increased in aged myoblasts.
Real time PCR for the expression of p53 and p21 on myoblasts
obtained from young (21.6 ± 2.23 year-old) and old
(73.37 ± 2.66 year-old) subjects. Data are represented as
average ± SEM. (p53: p = 0.02; p21: p = 0.03)
Fig. 7 Differentiation of aged satellite cells is compromised in
autologous culture conditions. Immunofluorescence analysis for
MyHC expression. Muscle differentiation was evaluated ana-
lysing the expression of MyHC, which resulted dramatically
reduced in aged satellite cells cultured in autologous serum (5 %
AS) and partially recovered in satellite cells cultured in
heterologous serum (5 % HS). Nuclei (blue) were stained with
Hoechst
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and absolute increase (reviewed in Brack and Rando
2007) (Snow 1977; Gibson and Schultz 1983; Conboy
et al. 2003; Sajko et al. 2004; Brack et al. 2005; Shefer
et al. 2006). However, a decline in the number of cells
expressing satellite cell markers or in a satellite cell
position seems to be the general tendency in humans
(Renault et al. 2002; Foulstone et al. 2003a, b;
Foulstone et al. 2004). Moreover, the decline in
satellite cells number seems to be more robust in the
fast-twitch extensor digitorum longus (EDL) rat
muscle compared to the slow-twitch soleus rat muscle
(Shefer et al. 2006), in accordance with the preferen-
tial loss and atrophy of fast-twitch fibers in sarcopenia.
Although the number of satellite cells appears to
decline with an increasing age, the expression levels of
the muscle regulatory factors (MRF), namely MyoD,
myf-5 and myogenin, appear to be upregulated, at
mRNA and protein level, in senescent muscle (Snij-
ders et al. 2009; Musaro et al. 1995; Edstrom and
Ulfhake 2005; Kim et al. 2005; Kosek et al. 2006;
Raue et al. 2006). Of note, in rodent muscle, the
magnitude of upregulation of MRF mRNA expression
appears to be proportional to the degree of sarcopenia
(Edstrom and Ulfhake 2005). It is conceivable that
these changes might operate as a compensatory
mechanism. However, we can speculate that satellite
cells fail to differentiate, or myonuclei turn up the
MRFs in an attempt to counteract atrophy. This can be
counteracted by exercise which has been described to
increase the number of satellite cells (Kadi et al. 1999,
Walker et al. 2012) but this number will also decline
with age even in athletes. Although no study has so far
evaluated the number of satellite cells in master
athletes, most of the studies on medium-term
(8–12 weeks) resistance training in older individuals
show an increase in satellite cell content (Mackey et al.
2007; Olsen et al. 2006; Roth et al. 2001; Verdijk et al.
2009; Verney et al. 2008). Thus, the increase in
satellite cell content represents a physiological
response to resistance exercise, preparing the muscle
for adaptation and for the generation of new myonu-
clei to facilitate muscle fiber hypertrophy (Snijders
et al. 2009).
Nevertheless, even if sarcopenia is associated with
a decline in the number of satellite cells, the remaining
resident satellite cells should be sufficient to activate
and sustain an adequate regenerative mechanism.
Indeed, it has been demonstrated that satellite cells
maintain their potential to respond to growth
promoting cues, undergo differentiation, fuse into
myotubes and give rise to reserve cells throughout life,
suggesting that impaired regeneration might be
inflicted by the aging environment and not necessarily
due to inherent changes in the cells themselves (Shefer
et al. 2006). This has been confirmed in humans where
satellite cells isolated from donors of varying age
show an initial decline of their proliferative capacity,
which then stabilizes in adults of all ages, with no
statistical difference between young adults and elderly
subjects (Decary et al. 1997, see Fig. 3). Thus, one of
the major questions concerning the influence of aging
on muscle regeneration is whether the reduction in
regenerative capacity is intrinsic to the muscle or
whether it is a function of the environment in which
the muscle is regenerating (Carlson 2003).
Heterochronic experiments have demonstrated that
old muscle successfully regenerates when transplanted
in a young animal, whereas the regeneration of young
muscle transplanted in an old host is impaired (Carlson
and Faulkner 1989; Carlson et al. 2001). This
hypothesis has been clearly validated by parabiotic
experiments, the union of two organisms that share the
circulatory system, demonstrating the rejuvenation of
aged progenitor cells by exposure to a young systemic
environment (Conboy et al. 2005). These results
emphasize the importance of the environment, which
is created by circulating factors, but also by the local
secretome of factors secreted by the cells, such as
satellite cells, the newly differentiating fibers, as well
as by the inflammatory context of the early steps of
muscle regeneration (Le Bihan et al. 2012). As an
example, we have shown that the presence of pro- or
anti-inflammatory macrophages will change the
dynamics of muscle regeneration (Bencze et al.
2012), and we show in this report the effect of
autologous versus heterologous and heterochronic
serum on differentiation. In addition, when skeletal
muscle biopsies from young and old males and
females were analysed for Insulin-like growth factor-
I (IGF-I), IL-6 and TNF-alpha protein levels, we
ascertained that males had higher local levels of all
three factors (IGF-I, IL-6 and TNF-alpha) compared
with females, regardless of age (data not shown).
However, for TNF-alpha alone, in both males and
females, age culminated in an increase in the local
skeletal muscle milieu of TNF-alpha (Fig. 8a), a
cytokine known to induce murine myoblast apoptosis
(Stewart et al. 2004) and to block human muscle cell
Biogerontology (2013) 14:273–292 281
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differentiation (Foulstone et al. 2004). The increase of
TNF-alpha with aging and inactivity was also associ-
ated with a significant increase in NFjB expression in
the muscle of male, but not of female, (Fig. 8b). As it
is well known, NFjB is a transcription factor that
controls the gene expression of numerous inflamma-
tory proteins, such as TNF-alpha. In addition to a
potential role for TNF-alpha in regulating muscle
mass with inactivity, Notch, Wnt, IGF-I, and myost-
atin may modulate the pathological niche. Notch
signaling is one of the major pathways that regulates
the activation and expansion of the satellite cell
lineage during embryogenesis (Vasyutina et al. 2007)
and cell fate, i.e. undifferentiated progenitor versus
differentiated progeny, in the adult (Conboy and
Rando 2002). The decline of Notch signaling with age
is thought to be one of the causes of the decrease in the
activity of satellite cells, and potentially the decreased
regenerative potential of satellite cells in aged mice
(Conboy et al. 2005). Indeed forced activation of
Notch signaling in injured muscle of aged mice
restores the regenerative potential of that tissue
(Conboy et al. 2003). In addition, the temporal balance
between Notch and Wnt signaling orchestrates the
precise progression of muscle precursor cells along the
myogenic lineage pathway, during postnatal myogen-
esis (Conboy et al. 2003). Nevertheless, Wnt signaling
must be finely modulated, since a persistence of Wnt
signaling, as for example is observed in aged mice, can
be associated with an increase in tissue fibrosis
(Chilosi et al. 2003; Brack et al. 2007; Jiang et al.
2006).
Fig. 8 TNFa levels and NFkB expression increase in the
muscle of old subjects. (a) Elisa assay to evaluate the
concentration of TNFa in muscles of young and old females
and males indicated. Data are represented as average ± SEM.
n = 12 old females, n = 17 young females, n = 15 old males,
n = 12 young males. (b) Left panel: western blot quantification
of phosphorylated active forms of NF-jB p65 subunit (P-p65).
Subjects were categorized by age (young, \40 years; and old,
[70 years) and by gender. Quantification was performed using
ImageJ software and normalized to b-tubulin used as loading
controls. *p \ 0.021, one-way ANOVA test; •p \ 0.001 and
Dp = 0.012, Student’ t test. Right panel shows representative
western blot analysis for P-p65 and total p65 in female and male
of different age
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Among the different growth factors, IGF-I has been
implicated in many anabolic pathways in skeletal
muscle and has been shown to play a central role
during muscle regeneration (Scicchitano et al. 2009;
Foulstone et al. 2004; Crown et al. 2000). Unlike other
growth factors IGF-I also stimulates myogenic differ-
entiation and generates a pronounced hypertrophy of
the muscle cells in vivo and in vitro (Musaro` and
Rosenthal 1999; Musaro` et al. 1999; Musaro` et al.
2001, Jacquemin et al. 2004), suggesting that this
growth factor can regulate both proliferative and
differentiation responses in muscle cells, the two
stages which guarantee the achievement of the regen-
erative program. IGF-I has been shown not only to
provoke hypertrophy, but can also recruit additional
satellite cells to the hypertrophic fibre by provoking
the release of IL13, thus ensuring a functional nuclear
domain to these fibres (Jacquemin et al. 2007).
Analyses of transgenic mice expressing different
IGF-I isoforms have provided insight into the role of
local IGF-I signaling in the physiology of striated
muscle (see also Sandri et al. 2013 this issue). By
controlling the transcription of IGF-I transgenes with
different promoters it has been possible to characterize
the role of the local and/or circulating form of IGF-I on
muscle cell and tissue function. Results from different
studies suggest that after muscle injury, the IGF-1Eb
isoforms are expressed first, followed by an increase in
the expression of the IGF-1Ea isoform; the peak of
IGF-IEb transcripts coincides with satellite cell and
myoblast proliferation, whereas the peak of IGF-IEa
mRNA is correlated with the maturation of the
myofibers (Shavlakadze et al. 2005). We have also
demonstrated that the local form of IGF-I (mIGF-I)
promotes an increased recruitment of proliferating
bone marrow cells to injured transgenic muscles and
modulates the inflammatory response, accelerating the
functional rescue of injured skeletal muscle (Musaro`
et al. 2004; Pelosi et al. 2007).
Other factors that have been shown to modulate
muscle regeneration belong to the family of trans-
forming growth factor-b (TGFbs) which are known to
suppress myogenic differentiation. Among these,
myostatin is a negative regulator of skeletal muscle
growth (Dominique and Gerard 2006; McPherron
et al. 1997; Kambadur et al. 1997; Schuelke et al.
2004; Carnac et al. 2006). Myostatin potentially
antagonizes muscle regeneration by limiting satellite
cell proliferation and differentiation. Injured muscles
lacking functional myostatin, exhibit improved regen-
eration and reduced fibrosis, while over expression of
myostatin leads to reduced muscle size and increased
wasting (Wagner 2005; Reisz-Porszasz et al. 2003;
Jespersen et al. 2006). However, the consequences of
these complex signaling interactions is not always
straight-forward, and even though inhibition of myo-
statin leads to muscle hypertrophy, whether it also
leads to an increase in specific force is highly debated
(Schirwis et al. 2012; Ploquin et al. 2012; Mendias
et al. 2011; Mendias et al. 2006; Personius et al. 2010),
and single-target pharmacological or genetic inter-
vention may result in adverse effects that could result
in a different outcome than initially thought. It has
been documented that blocking the effects of myost-
atin, not only renders the increased muscle mass more
susceptible to contraction-induced injury, but more
recently, using murine models, it has been shown that
myostatin deficiency resulted in an impaired structure
and function of tendon tissues (Mendias et al. 2008).
Recent studies also suggest that apoptosis might be
another mechanism involved in sarcopenia (Fulle et al.
2012; Marzetti et al. 2012). Compared with young
animals, a significant increase in muscle cell apoptosis
coupled with a decrease in gastrocnemius muscles
weight and muscle fiber cross-sectional area, of both
fast and slow fiber types, was noted in old mice
(Kovacheva et al. 2010; Sinha-Hikim et al. 2013a).
Oxidative stress (Marzetti et al. 2008), chronic
inflammation (Phillips and Leeuwenburgh 2005),
and impaired insulin sensitivity (Turpin et al. 2006)
seems to be potential candidates for the activation of
myonuclear apoptosis at old age.
Oxidative stress and sarcopenia
Emerging evidences have assigned to oxidative stress
a critical role in muscle homeostasis and in the
physiopathology of skeletal muscle (Musaro` et al.
2010; Fulle et al. 2005). There are evidences demon-
strating that ROS are not merely toxic species but also-
within certain concentrations-useful signaling mole-
cules regulating physiological processes (Musaro` et al.
2010). It is clear that transiently increased levels of
oxidative stress might reflect a potentially health
promoting process, while an uncontrolled accumula-
tion of oxidative stress might have pathological
implication. The first scientist who hypothesized a
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correlation between oxidative damage and senescence
was Harman in 1956 (Harman 1956). However, how
such an oxidative insult plays a direct role in the
disease-related decrease of muscle performance and
mass (atrophy) remains largely unknown. In addition,
the discrepancy among different studies has further
complicated the achievement of a conclusive link
between altered balance of ROS generation and
atrophy-associated diseases. Nevertheless, recent
reports contribute to clarify how the disruption of the
delicate balance between ROS production and anti-
oxidant defense may activates a cascade of events,
leading to muscle atrophy and wasting (Musaro` et al.
2010; Dobrowolny et al. 2008). Evidence in support of
this theory comes from observations that: (1) oxidative
damage to macromolecules accumulates with normal
aging, (2) variations in life span among different
species correlate inversely with rates of mitochondrial
generation of oxidant species, and (3) experimental
interventions which extend life span result in reduc-
tions in oxidative damage (Sohal and Weindruch
1996).
Superoxide dismutase (SOD) enzymes are antiox-
idants that protect cells from oxidative stress by
catalyzing the dismutation of superoxide to oxygen
and hydrogen peroxide. It has been previously reported
that SOD2 knockout mice exhibit reduced electron
transport chain components and lipid accumulation in
skeletal muscle (Li et al. 1995; Esposito et al. 1999).
Additionally, SOD2 knockout mice display a dilated
cardiomyopathy (Li et al. 1995; Lebovitz et al. 1996).
These studies, however, did not explicitly address the
importance of SOD2 function in the muscle for whole
organism vitality and longevity. Martin and colleagues
extended these previous reports demonstrating that the
selective knockdown of SOD2 in the musculature of
Drosophila is sufficient to shorten life span and to
accelerate locomotor declines (Martin et al. 2009).
Flies with knockdown of SOD2 in muscle exhibit
mitochondrial pathology, reduced ATP content, and
elevated caspase activity, suggesting that the conse-
quences of SOD2 loss in this tissue extend to the
viability of the organism as a whole. Another study, by
Zhang et al. (2009) suggested other interpretations
about the role of oxidative stress and longevity. It has
been previously reported that the single knock out in
two mitochondrial-localized antioxidant enzymes, Mn
superoxide dismutase (MnSOD) and glutathione per-
oxidase-1 (Gpx-1) displays altered mitochondrial
function, increased sensitivity to apoptosis, increased
cancer incidence, and susceptibility to oxidative stress,
without significantly altering the life span (Williams
et al. 1998; Esposito et al. 2000; Van Remmen et al.
2003; Lee et al. 2006). Because the antioxidant defense
system is a complex and integrated system, it is
possible that deficiency of a single antioxidant enzyme
may not compromise the system to a magnitude
sufficient to alter longevity. Of note, mice deficient in
both Mn superoxide dismutase and glutathione perox-
idase-1 have increased oxidative damage and a greater
incidence of pathology but no reduction in longevity
(Zhang et al. 2009). Moreover, other studies provided
direct evidence that age-associated increase in oxida-
tive stress plays a crucial role in neuromuscular
junction (NMJ) degeneration and progression of sar-
copenia (Jang and Van Remmen, 2011). Homozygous
deletion of SOD1 leads to age-dependent muscle
atrophy with alterations in NMJs that are similar to
normal aging muscle but with a more frequent and
earlier occurrence (Jang et al. 2010; Muller et al. 2006).
The complex situation between oxidative stress and
sarcopenia is not only evident in mature muscle fibers
but also in muscle resident satellite cells in which
some functional parameters, at least for that concerns
the Ca(2?) homeostasis, seem to be modified. It has
been reported an age-dependent increase of lipid
peroxidation, in cultured myotubes (Beccafico et al.
2007).
These evidences suggest that altered balance of
ROS production is a critical issue for the progression
of the diseases and that pathological conditions in
which oxidative stress is a common feature, such as
aging and disuses, may not be simply an issue of living
or dying, but rather an issue of functioning well versus
functioning poorly (Barzilai and Bartke 2009).
Conclusions
All of these findings demonstrate that sarcopenia has a
multi-factorial etiology, involving a great variety of
structural, biochemical and physiological abnormali-
ties. Moreover, with age, the systemic environment is
less effective in maintaining the myogenic fate of
muscle stem cells and, instead, facilitates conversion
to a fibrogenic fate, while the myogenic stem cells may
be more sensitive to their environment, thus amplify-
ing this phenomenon. The modifications with aging in
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the secretome of the different cell types present at
different phases of regeneration is probably then
crucial, as is expression of relevant cell surface
receptors, which can also change with age (e.g. IGF
and IGF receptors). Thus, while stem cells represent
an important determinant for tissue regeneration, a
‘‘qualified’’ environment is necessary to guarantee and
achieve functional results. In this context, therapeutic
applications of adult stem cells to aged or pathological
tissue repair in the context of regenerative medicine
will require an increased understanding of stem-cell
biology, of the cross-talk between the different cell
types involved and of the environment of the ageing or
pathological tissue.
Methods
Muscle biopsies
Biopsies from vastus lateralis or glutaeus medius
muscles were obtained from healthy patients who
underwent elective orthopedic surgery, after informed
consent. Based on age, the patients were divided in
two experimental groups: young individuals (n = 3)
of 30.3 ± 1.8 years old, and aged individuals, (n = 5)
of 83.3 ± 6.3 years old. Biopsies were performed
following the procedure described by Engel (1994).
For lifespan determination, p16 mRNA and Telo-
mere length measurements, five young (age range
15–24 year-old), and 10 old subjects : five old
sedentary (age range 72–80 year-old) and five old
active (age range 68–79 year-old), classified by clini-
cians on the basis of their examination and of
questionnaires on their lifestyle, were used.
Cell cultures
Satellite cell populations were isolated from muscle
fragments obtained from biopsies of healthy subjects
at various ages, as described in (Musaro and Barberi
2010). Briefly, the isolated muscles were dissociated
both mechanically, by mincing them into a coarse
slurry with scissors, and enzymatically, using two
different solutions: collagenase/dispase (Roche)
1 mg/ml in CMF (calcium and magnesium free PBS)
and subsequently collagenase type II (Sigma) 0.1 mg/
ml in PBS. The isolated cells were then filtered
through a 40 lm cell strainer and centrifuged at
1,200 rpm for 15 min to sediment the dissociated
cells. The pellet was resuspended in growth medium
(GM) (consisting of Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 20 % horse
serum), and the suspension was plated on cell culture
35 mm diameter dishes. The mixed population of cells
was then enriched for myoblasts, using the preplating
technique (Musaro` et al. 2010).
Cells were then grown on tissue culture plastic dishes
coated with collagen from calf skin (Sigma) and
cultured in DMEM supplemented with either 15 %
autologous serum (obtained from the same donor of
muscle biopsies) or 15 % heterologous serum (obtained
from young donor), and with 50 lg/ml of gentamycin.
For lifespan determination, in order to maintain the
cells in a proliferative state as much as possible, cells
were cultivated in growth medium consisting of 1 vol
m199 medium/4 vol DMEM (Invitrogen) supple-
mented with 20 % foetal calf serum (Invitrogen), and
50 lg/ml Gentamycin (Invitrogen). The myogenic
purity of the populations was monitored by immuno-
cytochemistry using desmin as a marker.
At 5–6 days, when myoblasts showed an elongated
phenotype, the myogenic cells were induced to
differentiate by reducing the percentage of serum
(Differentiation Medium: DMEM supplemented with
either 5 % autologous serum or 5 % heterologous
serum, and with 50 lg/ml of gentamycin).
Serum was prepared by the immediate centrifuga-
tion method from both young and aged donors. The
sera were heat-treated at 56 C for 30 min before use.
Immunofluorescence analysis
Proliferating and differentiated satellite cells were
fixed in 4 % paraformaldehyde and processed as
described (Musaro` and Rosenthal 1999). The nuclei of
plated cells were visualized using Hoechst staining.
We used the following antibodies: a monoclonal MF-
20 antibody (Hybridoma Bank); a monoclonal anti-
body against Pax-7 (Hybridoma Bank); a monoclonal
antibody against MyoD (Santa Cruz); a monoclonal
antibody against desmin (sigma); a monoclonal anti-
body against Ki67 (Dako).
Cell proliferation analysis
Cell proliferation was determined by cell counting and
BrdU incorporation. BrdU incorporation (for 3 h in
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cell culture) assay was performed according to the
manufacturer’s instructions (cell proliferation kit-
Amersham GE Healthcare).
ELISA
The human TNF-alpha ELISA assay was performed
using Bender MedSystems GmbH (Vienna, Austria).
Intra-and inter-assay variability are reportedly 6 %
and 9.3 %, respectively. Data were derived from
biopsies of n = 12 old females (73.9 ± 2.5 years),
n = 17 young females (22.1 ± 2.8 years), n = 15 old
males (74.4 ± 3.1) and n = 12 young (21.2 ± 3.3)
males.
RNA extraction, cDNA synthesis and quantitative
real time RT-PCR
Total RNA from myoblasts was extracted using Total
RNA Isolation-NucleoSpin RNA II (Macherey–Na-
gel), according to the manufactures’ instructions.
After cDNA was synthesized using Superscript III
Reverse Transcriptase kit (Invitrogen) according to
the manufactures’ instructions. Relative quantification
was performed by real time RT-PCR using Rotor gene
Q 6000 system (QIAGEN)). In brief, the following
primers for the targets genes were used: p53 F: 50-
TCTGACTGTACCACCATCCACTA-30, R: 50-CAA
ACACGCACCTCAAAGC-30; p21 F: 50-TGGACCT
GTCACTGTCTTGT-30, R: 50-TCCTGTGGGCGGA
TTAG-30. Gapdh (primers: F: 50-CATTGCCCTCA
ACGACCACTTTGT-30, R: 50-CATTGCCCTCAAC
GACCACTTTGT-30) was chosen as housekeeping
gene. Real time RT-PCR reactions were performed in
duplicate in the same run, using MESA GREEN
MasterMix Plus for SYBR Assay (Eurogentec). All
reactions consisted of an initial denaturation step at
95 C for 5 min, followed by 45 cycles of 95 C for
15 s and 60 C for 60 s. A referent sample (human
lymphoblastoid cell lines) was used as internal cali-
brator in each run. The DCt value was calculated by
subtracting the Ct value for housekeeping genes from
the Ct value for the target gene of the same sample.
The DDCt was then calculated by subtracting the DCt
value of the control sample (human lymphoblastoid
cell lines) from the DCt value of myoblasts. Relative
expression level was then determined by calculating
2-DDCt (Pfaffl 2004). All the measurements were
repeated twice and the mean of experiments was
considered.
Telomere length determination
Genomic DNA was extracted from myoblasts and
telomere length was measured by a qPCR based
method as previously described by Mamchaoui et al.
(Skeletal muscle 2011).
Statistical analysis
Results are shown as mean ± S.D. unless otherwise
stated. Student’s t test was used for comparison of the
means among groups (myoblasts from young and old).
The basic criteria for normality and homoscedasticity
have been tested by the Shapiro-Francia and Bartlett’s
tests. When normality or homogeneity of variance
were not verified, Kruskal–Wallis tests were com-
puted to compare groups. All statistical analyses were
performed using the software STATA v.9.0. (Stata
Corp. Texas, USA).
Western blot analysis
Frozen muscle biopsies were lysed in TEAD buffer
(Tris–HCl 20 mM pH 7.5, EDTA 1 mM, NaN3 1 mM,
DTT 1 mM) containing protease inhibitor cocktail
(Sigma-Aldrich, St. Louis, MO, USA) and phosphatase
Inhibitor Cocktail 2, (Sigma-Aldrich, St. Louis, MO,
USA), homogenized using a motor-driven homoge-
nizer and centrifuged at 25,000 g for 1 h at 4 C. The
supernatant containing the total protein extract was
quantified by Bradford’s method. Tissue lysates were
stored at -80 C until analysis. About 40 lg of the
total protein was separated in 12 % SDS-polyacrila-
mide gel and transferred to a nitrocellulose membrane
(Trans-Blot Transfer Medium, Bio Rad, Hercules, CA)
and immunoblotted under standard conditions with
primary antibodies, as follows: 1:500 rabbit monoclo-
nal C22B4 anti-NF-kB p65 (Cell Signalling Technol-
ogy, Millipore, Beverly MA USA), 1:500 rabbit
monoclonal 93H1 Phospho-NF-kB p65 (Ser536) (Cell
Signalling Technology, Millipore, Beverly MA USA),
and 1:10,000 mouse monoclonal SAP.4G5 anti-~b-
tubulin (Sigma-Aldrich, St. Louis, MO, USA). Anti-
mouse or anti-rabbit immunoglobulin G horseradish
peroxidase secondary antibodies and an enhanced
286 Biogerontology (2013) 14:273–292
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chemiluminescence detection kit were from Santa
Cruz Biotechnology, CA, USA).
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